Corbus Pharmaceuticals (NASDAQ:CRBP) traded ~10% higher on Tuesday after the U.S. Food and Drug Administration (FDA) granted another Fast Track designation for the cancer drug developer’s lead asset, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback